All patients (N = 28) | |
---|---|
Age (years) | |
 Median (range) | 66.1 (22–88) |
Sex | N |
 Male | 17 |
 Female | 11 |
Primary | N |
 Pancreas | 10 |
 Small intestine | 9 |
 CUP | 4 |
 Lungs | 1 |
 Rectum | 1 |
 Stomach | 1 |
 Kidney | 1 |
 Paraganglioma | 1 |
Grading | N |
 1 | 9 |
 2 | 14 |
 3 | 3 |
 Unknown |  |
Treatment response | |
 Treatment response | 23 |
 No response | 5 |
Nuclide | |
177Lutetium | 15 |
90Yttrium | 13 |
NETTER-1 protocol | Â |
 yes | 3 |
 no | 25 |
Cycles before follow-up | |
 1 | 24 |
 2 | 1 |
 4 | 3 |
Therapeutic Activity | |
 Mean (range) | 7.92 (4–30.2) |